PPT-iFR vs FFR-guided coronary revascularization

iFRSwedeheart 5year outcome Matthias Götberg MD PhD Skane University Hospital Lund University Sweden on behalf of the iFRSwedeheart investigators Within the past 12 months I or my spousepartner have had a financial interestarrangement or affiliation with the organizations listed below. brPage 1br IFR in the City Institute of Food Research brPage 2br brPage 3br brPage 4br IFR in the City Institute of Food Research What is FLS?. VFR - Visual flight rules. ceiling > 3000 . ft and . vis. > 5 mi. MVFR - Marginal visual flight rules. 1000 . ft . < ceiling < 3000 . ft or 3 mi < . vis. < 5 mi. IFR - Instrument flight rules. How to Market. Navy Community Recreation. OVERALL CLASSIFICATION: . UNCLASSIFIED. THIS PAGE: . UNCLASSIFIED. Marketing Community Rec. Introductions. Steve Buckley, N94P, . steve.buckley@navy.mil. . IFR . Group. . offers . a comprehensive solution for the meat processing . industry. . IFR . Meat is the solution to your accounting software issues. . You . can use this solution to manage all of your processing, distribution, and accounting needs. 1. IFR Charts. IFR Low. IFR High (above 18,000). Multiple charts cover the country. Not all cover the same amount of area and are oriented in different directions. 2. IFR Low Chart. 3. Houston. Airport Information. vs. FFR-guided . Coronary Intervention . –. . iFR. -SWEDEHEART. Matthias Götberg, . MD, . PhD. Department of Cardiology, Lund University. Skane. University Hospital. Lund, Sweden. Disclosures. Volcano/Philips: Unrestricted grant to fund . VIABILITY. CORONARY ARTERY DISEASE. ACUTE CORONARY SYNDROME. Undergo . revascularisation. procedures. . Improved survival. Increased number of patients with residual LV dysfunction undergoing progressive LV remodeling and congestive heart failure. Revascularization in Stable Ischemic Heart Disease. Bobby Mathew, MD. LSU Internal Medicine, HO-II. Definitions. Recommendations for revascularization in the setting of symptomatic, stable ischemic heart disease; does not include revascularization in the setting of acute MI. . Mark Nidorf, Aernoud Fiolet, Arend Mosterd, John Eikelboom, . Astrid Schut, Charley Budgeon, Jan Tijssen, Jan Hein Cornel, Peter Thompson. and the LoDoCo2 Investigators .  . Mark Nidorf has no declaration of interest . Gunjan. . Gholkar. MD. Metro Heart and Vascular. Objectives. Show lots of pretty pictures. Raise awareness of current indications and clinical scenarios for which to consider CT . angiography. Interpretation of reports. Functional Coronary Angiography in Symptomatic Patients with No Obstructive Coronary Artery Disease . Sonali Kumar MD, Puja K. Mehta MD, Parham Eshtehardi MD, Olivia Y. Hung MD, Jin-Sin Koh MD, Arnav Kumar MD,MSCR; Ahmed Al-Badri MD, Rani Rabah, Melroy D’Souza MD, Sonu Gupta MBBS, Michael McDaniel MD, Viola Vaccarino MD PhD, John Douglas MD, Kreton Mavromatis MD, Joo Myung Lee MD MPH PhD, Arshed Quyyumi MD, Habib Samady MD. vs.. . c. oronary artery bypass for multi-vessel disease: a meta-analysis. . Nirav C Patel MD, Jonathan M Hemli MD, Karthik Seetharam MD, Annapoorna Uttara BS, Derek R Brinster MD,. . Luigi Pirelli MD, Chad . S. Elissa Altin, MD. Assistant Professor . Yale University. VA Connecticut. Disclosures. I have no disclosures.. Learning Objectives. Prevalence of angina in women. Prevalence of non-obstructive disease in women. on behalf of the OPTIMUM Investigators. O. utcomes of . P. ercutaneous . Revasculariza. TI. on. for . M. anagement of . S. U. rgically. Ineligible Patients with . M. ultivessel or Left Main Coronary Artery Disease: Primary Results from the .